GW PHARMACEUTICALS PLC Shareholders' Equity
GW PHARMACEUTICALS PLC had Shareholders' Equity of $736.37 million as of 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2021-05-03
- 2021-03-31: Stockholders' Equity Attributable to Parent $736.37M.
- 2020-12-31: Stockholders' Equity Attributable to Parent $741.09M.
- 2020-09-30: Stockholders' Equity Attributable to Parent $734.45M.
- 2020-06-30: Stockholders' Equity Attributable to Parent $716.94M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2021-03-31 | $736.37M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $741.09M 10-Q · filed 2021-05-03 |
| 2020-09-30 | $734.45M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $716.94M 10-Q · filed 2020-11-05 |
| 2020-03-31 | $715.00M 10-Q · filed 2021-05-03 |
| 2019-12-31 | $726.03M 10-Q · filed 2021-05-03 |
| 2019-09-30 | $719.65M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $728.89M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $639.73M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $674.08M 10-K · filed 2021-02-26 |
| 2018-09-30 | $415.16M 10-K · filed 2021-02-26 |
| 2018-06-30 | $484.25M 10-Q · filed 2019-11-06 |
| 2018-03-31 | $564.60M 10-Q · filed 2019-11-06 |
| 2017-12-31 | $623.10M 10-Q · filed 2019-11-06 |
| 2017-09-30 | $380.82M 10-K · filed 2021-02-26 |
| 2016-09-30 | $525.67M 10-K · filed 2020-02-27 |
| 2015-09-30 | $386.89M 10-KT · filed 2019-02-28 |